For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...
A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.
This clinical-stage biotech develops targeted therapies for RAS/MAPK pathway-driven cancers, addressing hard-to-treat tumor ...
Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...
Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to ...
Tumors do not communicate only with immune cells, blood vessels, and stromal tissue. A growing body of evidence suggests that cancer can also co-opt the nervous system, reshaping the tumor ...
The researchers used lipid nanoparticles (LNPs) to deliver cyclic GMP-AMP (cGAMP) synthase (cGAS) mRNA to cancer cells. This results in production of the endogenous stimulator of interferon genes ...
Princeton researchers have resolved a decades-old mystery in cancer biology: vitamin A both fuels and undermines the immune ...
Majid Kazemian works with a team member in his lab. WEST LAFAYETTE, Ind. — Research from Purdue University in collaboration with the National Institutes of Health (NIH) reveals that a cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results